1

Identity

Roche Diagnostics, S.L.

B61503355

€402M

Amount awarded, solo awards 2016–2026

Amount awarded by year
YearAmountDistribution
2026*€68.2M
2025€96.5M
2024€39.9M
+ regional platforms
2023€36.3M
2022€28.9M
2021€65.2M
2020€38.8M
2019€13.8M
2018€9.6M
2017€4.0M
2016€0.9M
*2026: data to 31 October · 79 contracts in 2026 · Since 2024 this also includes data from regional platforms. · Solo awards, excluding JVs · Framework agreements at €0 · €M
868
Contracts (lots)
across 784 tenders
119
Buyers
83%
Single bidder
2
Awards in UTEs
not in the total

In figures

Volume

Between 2016 and 2026 it won 868 contracts worth €402M on its own, with 119 buyers. Its 2 joint-venture (UTE) contracts are shown separately.

Price

In 2024–2026 its median discount was 15.3%; the middle half of its discounts between 7.4% and 28.4% (28 comparable awards).

Competition

Since 2024, 25% of its comparable value was won with a discount and against other bidders. It was the only bidder in 83% of its contracts (2016–2026).

Renewals

109 contracts (€82.7M) come up for tender again in the next 24 months.

A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Roche Diagnostics, S.L.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Roche Diagnostics, S.L.'s share.

Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage

2

Its discounts

The discount at which it wins contested contracts, year by year.

2024–2026: median 15.3% · middle half between 7.4% and 28.4% · 28 awards

2017–2023: median 15.8% (59 awards) · 2024–2026: median 15.3% (28 awards).

2017–2026: median 15.5% · middle half between 5.9% and 24.5% · 87 awards

Discount on the tender budget, excluding VAT, on awards above the minor-contract threshold · Source: official data, national and regional coverage. Methodology →

Where it wins, and at what discount

In the report · these discounts, one by one

Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.

By sector

Productos farmacéuticos

CPV 336

171 contracts · €185M

Equipamiento médico

CPV 331

39 contracts · €10.5M

By buyer · 2024–2026

Departamento de Salud de Castellón. Dirección Económica-Gerencia

Productos farmacéuticos

14 contracts · €54.5M

Dirección General de Planificación Económica

Productos farmacéuticos

3 contracts · €31.8M

Centro de Gestion Integrada y Proyectos Corporativos

Productos farmacéuticos

17 contracts · €12.4M

Request the report →

Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.

Distribution of its discounts
How far winning bids are below the published contract value — its contested awards, the same ones the chart shows.
Median discount: 15.3% below the published contract value · 28 awards (2024–2026).
Discount
Awards
0–5 %
5
5–15 %
7
15–30 %
9
30 %+
7

20 awards at the tender price, left out of the discounts.

3

How it wins

Whether it wins with or without competition.

Competition and pricing

63% of the comparable value since 2024 (€80.9M of €128M) was won with a discount and without other bidders. €32.6M (25%) was awarded with a discount and against other bidders.

With a discount
63%
single bidder · 54 · €80.9M
25%
multiple bidders · 28 · €32.6M
At the tender price
11%
single bidder · 19 · €14.5M
0%
multiple bidders · 0

Comparable: 101 awards with a published budget and bidder count (€128M of €205M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.

Award procedure

Between 2016 and 2026, 82.1% of the value was awarded through open procedure (35.9% of contracts); followed by Negotiated without publicity (14.4%) and Based on a framework agreement (1.8%).

Open · 82.1%
Negotiated without publicity · 14.4%
Open
Simplified open
Based on a framework agreement
Negotiated without publicity
Other
4

Upcoming tenders and main buyers

When its contracts come back and who it sells to.

When its contracts come back

In the next 24 months 109 of its contracts come up for tender again, worth €82.7M.

Expected endBuyerValue
2026Hospital Universitario de Móstoles€112k
2026Jefatura de la Sección Económico Administrativa 15 Agrupación del Cuartel General del Ejército del Aire€75.4k
2026Organismo Autónomo Madrid Salud€60.9k
2026Hospital Universitario de Móstoles€23.0k
2026Hospital Universitario de Móstoles€20.7k

and 104 more in the next 24 months · the report includes them all

Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.

Who they sell to
BuyerContractsValue, €Period
Departamento de Salud de La Plana. Dirección Económica-Gerencia4585 M2017–2026
Secretaria General del Servicio de Salud de Castilla-La Mancha2648 M2020–2026
Gerencia Sector Sanitario de Zaragoza 27244 M2018–2026
Dirección General de Planificación Económica1840 M2019–2026
OSAKIDETZA - Servicio Vasco de Salud -Director General437 M2024–2026

and 114 more buyers

Sector activity
Top CPV codes — the EU classification system that identifies the type of works, services or supplies covered by each contract.

Between 2016 and 2026, 95.1% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 749 contracts); followed by Lab & precision instruments (CPV 38), with 1.7%.

Medical & pharmaceuticals
95.1%749 contracts
Lab & precision instruments
1.7%27 contracts
Repair & maintenance
1.7%19 contracts
Furniture & cleaning supplies
0.5%1 contract
Research & development
0.3%1 contract
5

Recent awards

The evidence behind every insight in the report.

Latest 5 completed contracts (of 216)
Contracts whose expected completion date has passed.
DateContractBuyerBiddersValue
26/10/2026cbam 33-02 am 1001/2023 - roche diagnostics s.l.u. - analizador marcadores cardiacos - agss (cs ron…Servicio Andaluz de Salud1€19.6k
26/08/2026cbam 34-02 am 1001/2023 - roche diagnostics s.l.u. - analizador de proteina c-reactiva-pcr - cs san…Servicio Andaluz de Salud1€10.5k
26/08/2026cbam 33-01 am 1001/2023 - roche diagnostics s.l.u. - analizador marcardores cardiacos - suap las la…Servicio Andaluz de Salud1no data
26/08/2026cbam 33-01 am 1001/2023 - roche diagnostics s.l.u. - analizador marcardores cardiacos - suap las la…Servicio Andaluz de Salud1no data
03/08/2026huj (dsjjs 2026 fase iv am 837/2023 roche diagnostics, s.l suministro de equipamiento para atención…Servicio Andaluz de Salud1€7.00k
Full report on Roche Diagnostics, S.L.
Includes: its discount by buyer and sector · winning discounts by buyer and year · how it wins with each buyer · contract renewal calendar. The complete register of its awards in the last three full calendar years and the current year to date, in Excel.
€50 + VAT · VAT is calculated at payment according to your country. You will receive it in PDF and Excel by email within one working day. Every report is reviewed by a person before it is sent to you.
Order the report